FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Glenmark Generics Naproxen Tablets Recall

NAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufactured by: G…

Glenmark Generics Inc., USA · Mahwah, NJ

Risk level
Class II
Reported by FDA
Oct 3, 2012
Recall ID
D-1701-2012
Check your lot numberHow we source this data

Summary

Glenmark Generics recalled Naproxen Tablets starting Jul 6, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1701-2012 on Oct 3, 2012. Reason: Labeling: Label Mix-Up: Bottles labeled as Naproxen Tablets USP, 500 mg, 100-count may contain 90-count Pravastatin Sodium Tablets, 40 mg. Status: Terminated.

Why it was recalled

Labeling: Label Mix-Up: Bottles labeled as Naproxen Tablets USP, 500 mg, 100-count may contain 90-count Pravastatin Sodium Tablets, 40 mg.

Product description

NAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufactured by: Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Generics Inc., USA, Mahwah, NJ 07430; NDC 68462-190-01.

Lot numbers, UPCs & expiration codes

Lot #: 02112930, 02112934, 02112941, Exp 09/14; 2112985, 02112986, 02113334, Exp 10/14; 02113360, 02113372, 02113420, 02113606, 02113663, 02113664, Exp 11/14.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1701-2012
Classification
Class II
Status
Terminated
Recall initiated
Jul 6, 2012
FDA report date
Oct 3, 2012
Quantity
unknown
Recall type
Voluntary: Firm initiated
Recalling firm
Glenmark Generics Inc., USA

Original FDA data

Every field from FDA enforcement report D-1701-2012, exactly as published.

Show all FDA fields
City
Mahwah
State
NJ
Status
Terminated
Country
United States
Event ID
63264
Address
750 Corporate Dr
Code information
Lot #: 02112930, 02112934, 02112941, Exp 09/14; 2112985, 02112986, 02113334, Exp 10/14; 02113360, 02113372, 02113420, 02113606, 02113663, 02113664, Exp 11/14.
Postal code
07430-2009
Report date
Oct 3, 2012
Product type
Drugs
Recall number
D-1701-2012
Classification
Class II
Recalling firm
Glenmark Generics Inc., USA
Product quantity
unknown
Termination date
Aug 13, 2015
Reason for recall
Labeling: Label Mix-Up: Bottles labeled as Naproxen Tablets USP, 500 mg, 100-count may contain 90-count Pravastatin Sodium Tablets, 40 mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
NAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufactured by: Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Generics Inc., USA, Mahwah, NJ 07430; NDC 68462-190-01.
Distribution pattern
Nationwide
Recall initiation date
Jul 6, 2012
Initial firm notification
Letter
Center classification date
Sep 27, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1701-2012, published Oct 3, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls